He-Sheng Luo Selected Research

He-Sheng Luo Research Topics

Disease

31	Neoplasms (Cancer) 10/2020 - 06/2002
16	Stomach Neoplasms (Stomach Cancer) 02/2015 - 05/2003
13	Colonic Neoplasms (Colon Cancer) 09/2017 - 01/2003
11	Colorectal Neoplasms (Colorectal Cancer) 08/2018 - 03/2003
11	Carcinoma (Carcinomatosis) 02/2015 - 11/2002
10	Lymphatic Metastasis 02/2015 - 05/2003
9	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2003
9	Carcinogenesis 08/2005 - 06/2002
8	Adenocarcinoma 12/2005 - 11/2002
5	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2017 - 09/2004
5	Adenoma (Adenomas) 06/2013 - 01/2003
5	Liver Cirrhosis (Hepatic Cirrhosis) 10/2010 - 01/2006
4	Infections 08/2018 - 11/2002
3	Gastritis 01/2017 - 05/2003
3	Fibrosis (Cirrhosis) 10/2010 - 01/2006
3	Hepatocellular Carcinoma (Hepatoma) 05/2008 - 06/2002
3	Metaplasia 12/2005 - 05/2003
3	Colitis 08/2005 - 11/2003
3	Ascites 01/2004 - 11/2003
2	Inflammation (Inflammations) 08/2018 - 09/2009
2	Atrophic Gastritis 02/2015 - 05/2003
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2015 - 01/2015
2	Stomach Ulcer (Gastric Ulcer) 01/2007 - 09/2006
2	Hypoxia (Hypoxemia) 11/2003 - 03/2003
1	Pancreatitis 10/2019

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2003
16	Messenger RNA (mRNA)IBA 01/2017 - 03/2003
10	NF-kappa B (NF-kB)IBA 01/2007 - 01/2003
8	ParaffinIBA 01/2007 - 01/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2005 - 03/2003
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2005 - 06/2002
4	Biomarkers (Surrogate Marker)IBA 10/2020 - 04/2010
4	LeptinIBA 09/2011 - 12/2005
4	Therapeutic UsesIBA 10/2010 - 11/2003
4	EnzymesIBA 04/2007 - 11/2003
4	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2007 - 01/2006
4	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2004 - 09/2003
3	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 10/2019 - 09/2006
3	Tryptases (Tryptase)IBA 01/2017 - 01/2007
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2015 - 06/2002
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014 - 01/2008
3	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 11/2002
3	Leptin ReceptorsIBA 09/2011 - 12/2005
3	Potassium Channels (Potassium Channel)IBA 04/2010 - 02/2007
3	Ether (Diethyl Ether)IBA 04/2010 - 02/2007
3	Thalidomide (Thalomid)FDA Link 01/2007 - 01/2006
2	CateninsIBA 08/2018 - 06/2016
2	RNA (Ribonucleic Acid)IBA 06/2016 - 05/2003
2	Small Interfering RNA (siRNA)IBA 06/2016 - 01/2015
2	Matrix Metalloproteinases (MMPs)IBA 02/2015 - 11/2003
2	Propidium (Propidium Iodide)IBA 01/2015 - 12/2014
2	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2015 - 01/2015
2	thiazolyl blueIBA 01/2015 - 12/2014
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2014 - 08/2005
2	FITC-annexin A5IBA 12/2014 - 01/2013
2	Decitabine FDA Link 02/2013 - 08/2012
2	WortmanninIBA 02/2013 - 07/2008
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2011 - 01/2008
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2011 - 01/2008
2	AntioxidantsIBA 10/2010 - 01/2006
2	Butyric Acid (Butanoic Acid)IBA 08/2007 - 04/2004
2	ImmunosorbentsIBA 04/2007 - 11/2003
2	Cholecystokinin B ReceptorIBA 12/2006 - 02/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 12/2003
2	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 04/2005 - 04/2004
2	Transcription Factors (Transcription Factor)IBA 11/2004 - 03/2004
2	CytokinesIBA 11/2004 - 03/2004
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2004 - 11/2002
2	OligodeoxyribonucleotidesIBA 02/2004 - 09/2003
2	Estrogen ReceptorsIBA 01/2004 - 12/2002
2	Formaldehyde (Formol)FDA Link 01/2004 - 03/2003
2	Saline SolutionIBA 12/2003 - 11/2003
2	Mesalamine (Mesalazine)FDA LinkGeneric 12/2003 - 11/2003
2	nimesulide (Aulin)IBA 05/2003 - 06/2002
1	Long Noncoding RNAIBA 10/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	Cadherins (E-Cadherin)IBA 08/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2017
1	KN 93IBA 09/2017
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2017
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2017
1	polaprezinc (Z 103)IBA 01/2017
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2017
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2017
1	matrigelIBA 06/2016
1	NeuropeptidesIBA 05/2016
1	Proteinase-Activated ReceptorsIBA 05/2016
1	PAR-2 ReceptorIBA 05/2016
1	matrix metalloproteinase 25IBA 02/2015
1	Matrix Metalloproteinase 17IBA 02/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2015
1	ArtesunateIBA 01/2015
1	artemisinin (artemisinine)IBA 01/2015
1	Annexin A5IBA 01/2015

Therapy/Procedure

3	Therapeutics 01/2017 - 10/2007
3	Drug Therapy (Chemotherapy) 07/2008 - 05/2003
3	Intraperitoneal Injections 01/2006 - 01/2006
3	Enema (Enemas) 08/2005 - 11/2003
2	Lasers (Laser) 05/2015 - 06/2013